267 related articles for article (PubMed ID: 18600594)
1. World Asthma and COPD Forum. Clinical trial results with omalizumab.
D'Amato G
IDrugs; 2008 Jul; 11(7):489-92. PubMed ID: 18600594
[No Abstract] [Full Text] [Related]
2. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
Casale TB;
Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab and the treatment of allergic rhinitis.
Kaliner MA
Curr Allergy Asthma Rep; 2004 May; 4(3):237-44. PubMed ID: 15056407
[TBL] [Abstract][Full Text] [Related]
4. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab.
Easthope S; Jarvis B
Drugs; 2001; 61(2):253-60; discussion 261. PubMed ID: 11270941
[TBL] [Abstract][Full Text] [Related]
6. Immunological intervention with anti-immunoglobulin-E antibody to prevent asthma exacerbations.
Chanez P
Eur Respir J; 2001 Aug; 18(2):249-50. PubMed ID: 11529279
[No Abstract] [Full Text] [Related]
7. Omalizumab: a novel monoclonal antibody for treatment of allergic disease.
Piascik P
J Am Pharm Assoc (Wash); 2002; 42(2):356, 358. PubMed ID: 11926671
[No Abstract] [Full Text] [Related]
8. [Anti IgE antibodies for the treatment of difficult asthma].
Humbert M; Tonnel AB
Rev Mal Respir; 2005 Dec; 22(6 Pt 1):983-90. PubMed ID: 16222222
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab in asthma: is the therapeutic window too small?
Bhat KD; Calhoun WJ
Chest; 2011 Jan; 139(1):8-10. PubMed ID: 21208873
[No Abstract] [Full Text] [Related]
10. [Severe asthma, IgE and anti-IgE: from sceptical waiting to factual learning].
Blanc FX
Rev Mal Respir; 2005 Dec; 22(6 Pt 1):925-7. PubMed ID: 16220115
[No Abstract] [Full Text] [Related]
11. Omalizumab (Xolair): an anti-IgE antibody for asthma.
Med Lett Drugs Ther; 2003 Aug; 45(1163):67-8. PubMed ID: 12915804
[No Abstract] [Full Text] [Related]
12. Omalizumab for asthma: indications, off-label uses and future directions.
Ben-Shoshan M
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):183-92. PubMed ID: 20807194
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis.
Félix Toledo R; Negro Alvarez JM; Miralles López JC
Allergol Immunopathol (Madr); 2002; 30(2):94-9. PubMed ID: 11958741
[TBL] [Abstract][Full Text] [Related]
14. Anti-IgE treatment: an update.
Babu KS; Arshad SH; Holgate ST
Allergy; 2001 Dec; 56(12):1121-8. PubMed ID: 11736740
[No Abstract] [Full Text] [Related]
15. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
Dodig S; Richter D; Cepelak I; Benko B
Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
[TBL] [Abstract][Full Text] [Related]
16. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
Leuenberger P; Sauty A; Rochat T
Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
[TBL] [Abstract][Full Text] [Related]
17. Anti-IgE in allergic asthma and rhinitis: an update.
Morjaria JB; Gnanakumaran G; Babu KS
Expert Opin Biol Ther; 2007 Nov; 7(11):1739-47. PubMed ID: 17961096
[TBL] [Abstract][Full Text] [Related]
18. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
Nowak D
Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in asthma: approval and postapproval experience.
Chiang DT; Clark J; Casale TB
Clin Rev Allergy Immunol; 2005 Aug; 29(1):3-16. PubMed ID: 16222080
[TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
